ArticleFrontiers in oncology2025
High-performance CT features supporting accurate pre-operative tumor staging in colon cancer.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Preoperative colon cancer nodal staging using dual-energy CT and clinically derived features.European radiology · 2026Article
- Diagnostic accuracy of dual-layer spectral computed tomography virtual monoenergetic imaging with multiplanar reformation for T-staging of colorectal cancer.World journal of gastroenterology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and aims: Accurate pre-treatment tumor staging is essential for treatment decision-making. Multi-slice spiral computed tomography (CT) is currently the standard method for pre-operative clinical tumor staging, but accurately applying the CT findings in tumor staging remains a challenge due to the poor pathological understanding of the CT signs. We aimed to pathologically interpret the key CT findings in order to identify reliable markers for pre-treatment staging of colon cancer. Patients and methods: The following CT features from 136 colon adenocarcinomas were analyzed: colon wall pliability, outline contour, pericolic fat attenuations and vascularity, tumor fusion with adjacent organs, ascites, tumor size, and relevance between tumor and retroperitoneal fascia. These CT features were corroborated with histopathological findings. The diagnostic performance of these was further analyzed. Results: Based on the postoperative pathological tumor staging (pT), 136 colon adenocarcinomas were classified into four stages: pT1 (n = 5), pT2 (n = 7), pT3 (n = 96), and pT4 (n = 28). Key findings include the following: (1) soft colon wall is a characteristic of the pT1 tumors, whereas stiff colon wall is a characteristic of the pT2~pT4 tumors; pathologically, stiff colon wall reflects the infiltration of tumor cells with desmoplastic reaction (DR) in muscularis propria; (2) small protuberances may help exclude the pT2 tumors. Histopathologically, small protuberances in pT2 cancer represent the pure DR on the surface of lamina propria, whereas the small protuberances in pT3~pT4 cancers represent the sub-serosal or extra-serosal cancer cell foci enwrapped by DR; (3) the presence of large protuberances, extensive reticulonodular fat stranding, and fusion with surrounding organs and ascites are diagnostic of pT4 tumors; and (4) the presence of extra-fascial nodules/streaks on CT scan could accurately diagnose the ascending/descending colon cancer of pT4 stage. Histologically, the presence of the above five CT features (large protuberances, extensive reticulonodular fat stranding, fusion with surrounding organs, ascites, and extra-fascial nodules/streaks) reflect the farther and deeper infiltration of tumor cells in serosa or retroperitoneal fascia involvement. Conclusion: Our studies have identified multiple CT features that are practically useful in identifying and differentiating different stages of colon cancer prior to surgical procedures. These high-performance markers will provide valuable insights to the clinicians in making appropriate decisions in the management of patients with colon cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.